AQR Arbitrage’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

AQR Arbitrage’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-136,895	Closed	-$8.51M	–	710
2023 Q4	$8.51M	Buy	+136,895	New	+$3.4M	0.34%	78

AQR Arbitrage's RYZB Position: Q1 2024 in Review

AQR Arbitrage sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 136,895 shares — an estimated $8.51M sold.

AQR Arbitrage first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $8.51M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

AQR Arbitrage reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
AQR Arbitrage sold 136,895 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $8.51M.
AQR Arbitrage first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
AQR Arbitrage's RayzeBio, Inc. Common Stock position peaked at $8.51M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on AQR Arbitrage's 13F filing for Q1 2024, filed 15 May 2024.